Literature DB >> 17692028

Targeting protein multiple conformations: a structure-based strategy for kinase drug design.

Jeffrey Jie-Lou Liao1, Robert C Andrews.   

Abstract

Multiple conformations of a protein kinase target offer an opportunity to design small-molecule inhibitors with distinct but clinically useful profiles. This article analyzes and classifies the binding pockets in the kinase catalytic cleft in different conformational states. Targeting kinase multiple conformations as an emerging strategy in the field is exemplified with important small-molecule agents in the clinic. The structure-based analysis in the paper provides a rationale for thwarting the development of drug-resistant mutations in antikinase therapy.

Mesh:

Substances:

Year:  2007        PMID: 17692028     DOI: 10.2174/156802607781696783

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  12 in total

1.  Simultaneous protein expression and modification: an efficient approach for production of unphosphorylated and biotinylated receptor tyrosine kinases by triple infection in the baculovirus expression system.

Authors:  Dirk Erdmann; Catherine Zimmermann; Patrizia Fontana; Jean-Christophe Hau; Alain De Pover; Patrick Chène
Journal:  J Biomol Tech       Date:  2010-04

2.  Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.

Authors:  Ronak Y Patel; Robert J Doerksen
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

3.  KLIFS: a structural kinase-ligand interaction database.

Authors:  Albert J Kooistra; Georgi K Kanev; Oscar P J van Linden; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  Nucleic Acids Res       Date:  2015-10-22       Impact factor: 16.971

Review 4.  Chiral kinase inhibitors.

Authors:  Jian-kang Jiang; Min Shen; Craig J Thomas; Mathew B Boxer
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 5.  Recent developments of protein kinase inhibitors as potential AD therapeutics.

Authors:  Volkmar Tell; Andreas Hilgeroth
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

6.  In silico study on Penicillin derivatives and Cephalosporins for upper respiratory tract bacterial pathogens.

Authors:  K M Kumar; P Anitha; V Sivasakthi; Susmita Bag; P Lavanya; Anand Anbarasu; Sudha Ramaiah
Journal:  3 Biotech       Date:  2013-06-11       Impact factor: 2.406

7.  Molecular Docking and Molecular Dynamics to Identify a Novel Human Immunodeficiency Virus Inhibitor from Alkaloids of Toddalia asiatica.

Authors:  R Priya; Rajendrarao Sumitha; C George Priya Doss; C Rajasekaran; S Babu; R Seenivasan; R Siva
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

8.  Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation.

Authors:  William A Denny; Jack U Flanagan
Journal:  Biomolecules       Date:  2021-11-10

9.  Detection of OXA-1 β-lactamase gene of Klebsiella pneumoniae from blood stream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance.

Authors:  Madhan Sugumar; K M Kumar; Anand Manoharan; Anand Anbarasu; Sudha Ramaiah
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

Review 10.  Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action.

Authors:  Paweł Łukasik; Irena Baranowska-Bosiacka; Katarzyna Kulczycka; Izabela Gutowska
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.